Agenus Inc. (NASDAQ:AGEN) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Ethan Lovell - Chief of External Affairs & Communications Officer Garo Armen - Chairman & Chief Executive Officer Christine Klaskin - Vice President-Finance Steven O'Day - Chief Medical Officer Dhan Chand - Scientific Director, Head of Drug Discovery Conference Call Participants Mayank Mamtani - B. Riley Securities Matt Phipps - William Blair Operator Good morning. My name is Abby and I will be your con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of incorporation ...

Agenus Inc. (NASDAQ:AGEN) Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Christine Klaskin - Vice President of Finance, Principal Financial Officer & Principal Accounting Officer Dhan Chand - Scientific Director & Head of Drug Discovery Ethan Lovell - Chief External Affairs and Communications Officer Garo Armen - Founder, Executive Chairman & Chief Executive Officer Steven O’Day - Chief Medical Officer Conference Call Participants Mayank Mamtani - B. Riley Securities Matthew Ph ...

Agenus Inc. (NASDAQ:AGEN) Q4 2021 Earnings Conference Call March 1, 2022 8:30 AM ET Company Participants Divya Vasudevan – Senior Director, Oncology Strategy and Investor Relations Garo Armen – Chairman and Chief Executive Officer Steven O'Day – Chief Medical Officer Chandresh Harjivan – Chief Operating Officer of SaponiQx Christine Klaskin – Vice President of Finance Conference Call Participants Jason Bouvier – Jefferies Mayank Mamtani – B. Riley Mike King – H.C. Wainwright Hunter Rogers – William Blair Op ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of (I.R.S. Employer i ...

Agenus Inc. (NASDAQ:AGEN) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Divya Vasudevan - Investor Relations Garo Armen - Chairman and Chief Executive Officer Jennifer Buell - Chief Executive Officer, MiNK Therapeutics Steven O’Day - Chief Medical Officer Christine Klaskin - Vice President, Finance Conference Call Participants Mayank Mamtani - B. Riley Securities Jason Bouvier - Jefferies Matt Phipps - William Blair Operator Good day and thank you for standing by. Welcome ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of incorpora ...